scholarly article | Q13442814 |
P50 | author | William Rostène | Q28872703 |
Stéphane Mélik Parsadaniantz | Q56512551 | ||
Nicolas Beaudet | Q57561132 | ||
P2093 | author name string | Philippe Sarret | |
Marc-André Dansereau | |||
Patrick Kitabgi | |||
Michel Pohl | |||
Annie Mauborgne | |||
Blandine Pommier | |||
Romain-Daniel Gosselin | |||
Patricia Mechighel | |||
P2860 | cites work | Interleukin-8 as a mediator of sympathetic pain | Q35871781 |
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. | Q40364641 | ||
Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol | Q46740233 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 13 | |
P304 | page(s) | 757-769 | |
P577 | publication date | 2008-04-17 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats | |
P478 | volume | 106 |
Q52728066 | Activation of Astrocytes and Microglial Cells and CCL2/CCR2 Upregulation in the Dorsolateral and Ventrolateral Nuclei of Periaqueductal Gray and Rostral Ventromedial Medulla Following Different Types of Sciatic Nerve Injury. |
Q47389897 | Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats. |
Q44340800 | Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys |
Q41469051 | Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain |
Q36309229 | CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis |
Q39279011 | CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice |
Q54378064 | CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. |
Q97524671 | CCL2/CCR2 system in neuroepithelial radial glia progenitor cells: involvement in stimulatory, sexually dimorphic effects of maternal ethanol on embryonic development of hypothalamic peptide neurons |
Q48187127 | CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy |
Q89961859 | CX3CR1 contributes to streptozotocin-induced mechanical allodynia in the mouse spinal cord |
Q36082738 | Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain |
Q42159792 | Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices |
Q37323999 | Chemokine action in the nervous system |
Q37507494 | Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons |
Q37215729 | Chemokines and pain mechanisms. |
Q39227824 | Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. |
Q37684327 | Chemokines, neuronal-glial interactions, and central processing of neuropathic pain |
Q91699852 | Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats |
Q33866116 | Contribution of the chemokine (C-C motif) ligand 2 (CCL2) to mechanical hypersensitivity after surgical incision in rats |
Q46297733 | DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1. |
Q92642853 | Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage |
Q47298502 | Ethanol and Cytokines in the Central Nervous System |
Q35122783 | Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia |
Q52571505 | Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice. |
Q37051472 | Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation |
Q84092189 | Extracellular matrix proteoglycan plays a pivotal role in sensitization by low pH of mechanosensitive currents in nociceptive sensory neurones |
Q37115195 | Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development |
Q36122082 | Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production |
Q64896004 | Hypothalamic CCL2/CCR2 Chemokine System: Role in Sexually Dimorphic Effects of Maternal Ethanol Exposure on Melanin-Concentrating Hormone and Behavior in Adolescent Offspring. |
Q44031587 | Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain. |
Q37442704 | Influence of the vanilloid receptor TRPV1 on the activation of spinal cord glia in mouse models of pain |
Q33965479 | Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic pain |
Q42155319 | Interferon-gamma potentiates NMDA receptor signaling in spinal dorsal horn neurons via microglia-neuron interaction |
Q91703368 | Interferon-γ facilitates the synaptic transmission between primary afferent C-fibres and lamina I neurons in the rat spinal dorsal horn via microglia activation |
Q39079653 | Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia |
Q37194288 | JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain |
Q31126222 | Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131). |
Q90719812 | Macrophage biology in the peripheral nervous system after injury |
Q37420652 | Microglia and neuropathic pain |
Q41786321 | Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons |
Q28582114 | NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9 |
Q37896669 | Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. |
Q26864449 | Neuroendocrine immunoregulation in multiple sclerosis |
Q38167771 | Neuropathic pain and cytokines: current perspectives |
Q64966538 | Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats. |
Q38318330 | Opioid and chemokine receptor crosstalk: a promising target for pain therapy? |
Q40842430 | PKC-NF-κB are involved in CCL2-induced Nav1.8 expression and channel function in dorsal root ganglion neurons |
Q37080681 | Paeoniflorin and Albiflorin Attenuate Neuropathic Pain via MAPK Pathway in Chronic Constriction Injury Rats |
Q36639036 | Pain in experimental autoimmune encephalitis: a comparative study between different mouse models |
Q35860828 | Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development |
Q24646738 | Pathological and protective roles of glia in chronic pain |
Q33925677 | Pathological pain and the neuroimmune interface |
Q99724582 | Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain |
Q38246264 | Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines? |
Q35561030 | Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat |
Q90712908 | Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway |
Q91914143 | Spinal mechanisms of neuropathic pain: Is there a P2X4-BDNF controversy? |
Q35168721 | Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators |
Q34113663 | Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344 |
Q89210678 | Sustained stimulation of β2- and β3-adrenergic receptors leads to persistent functional pain and neuroinflammation |
Q97075152 | The Delayed-Onset Mechanical Pain Behavior Induced by Infant Peripheral Nerve Injury Is Accompanied by Sympathetic Sprouting in the Dorsal Root Ganglion |
Q64892118 | The Role of Chemokines in the Pathophysiology of Major Depressive Disorder. |
Q46133545 | The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gβγ-dependent mechanism |
Q37677143 | The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction |
Q39038441 | The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain |
Q36717118 | Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain |
Q30500291 | Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain |
Q47877991 | WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms |
Search more.